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Schistosomiasis, a neglected and most prevalenttropical diseases after malaria, have been a threat to 
people living in endemic areas. With regards to possible resistance to the popular drug (praziquantel) 
use for treatment of schistosomiasis, the need for a permanent vaccinating approach has been 
justified. This study uses an in silico approach to identify potential target vaccine candidate or T cell 
epitopes (T cell response activating epitope) for the treatment of schistosomiasis. This research 
therefore identified some candidate T cell epitopes from Sm23 protein of Schistosma mansoni using 
immunoinformatics tools. Nonameric epitopes like 
85
YMYAFFLVV
93
, 
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MLYMYAFFL
91
, 
8
MRCLKSCVF
16
, 
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SQYGDNLHK
49
 and 
104
VAVVYKDRI
112 
was found to exhibit strong binding affinity with some human 
leukocyte antigen (HLA). The predicted epitope was found to have no similarity with human proteome, a 
good attribute that is conferred on any good vaccine candidate. The predicted epitopes provide 
promising drug candidates and could be tested by wet laboratory as targeted vaccine against S. 
mansoni infection.  
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INTRODUCTION 
 
Schistosomiasis is well-known as a significant public 
health problem in tropical and sub-Sahara Africa 
countries, despite the existence of effective drugs against 
the parasite. An estimated 732 million persons are 
vulnerable to schistosoma infection worldwide in 
renowned transmission areas (Onile et al., 2014; 
Adenowo et al., 2015). In 2008, 17.5 million people were 
treated globally for schistosomiasis, 11.7 million of these 
are from sub-Saharan Africa only. Approximately, 120 
million individuals in sub-Saharan Africa have 
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schistosomiasis-related symptoms while about 20 million 
undergo hardship as a result of chronic presentations of 
the disease (Adenowo et al., 2015). 
The identification of a promising and sensitive vaccine 
candidate against schistosomiasis is important to help 
connect chemotherapy approach in controlling disease 
transmission (Fonseca et al., 2012). Epitopes based 
vaccines could provide a new strategy for the 
prophylactic and therapeutic application of pathogen 
specific immunity (Shah et al., 2010). T cell-based 
immunological responses are triggered by peptide 
antigens (T cell epitopes) by the major histocompatibility 
complex (MHC) molecules (also known as human 
leukocyte antigen –HLA complex in human). This 
immunogenicity is dependent on several events; effective 
processing of the peptide from its protein source, stable 
peptide binding to the HLA molecule, and recognition of 
the HLA-bound peptide by the T cell receptor. Therefore, 
predicting HLA-peptide binding constitutes the principal 
basis for anticipating potential T cell epitopes and thus 
emphasises the relevance of epitope identification in 
vaccine design. Clinical trials of epitope based vaccines 
for human immunodeficiency virus, malaria and 
tuberculosis have produced promising results and thus 
support the identification and selection of T cell epitopes 
as vaccine candidates (Shah et al., 2010).  
Sm23 belongs to the family of "cysteine-rich, 
hydrophobic proteins," which are expressed on 
mammalian hematopoietic cells or tumour cells. Sm23 
shares the highly conserved hydrophobicity profile of 
these proteins, which predict four transmembrane 
segments, but is in addition linked to the membrane by a 
glycosylphosphatidylinositol (GPI) anchor. Sm23 is an 
integral membrane protein of the blood-vessel dwelling 
parasitic worm Schistosoma mansoni, which has been 
confirmed to be expressed in all schistosome life stages 
examined and in several tissues, including the adult 
tegument and therefore is of interest as a potential 
vaccine candidate (Reynolds et al., 1993; Carina et al., 
2011).  
Therefore identifying Sm23 T cell epitope-based 
vaccine will provide a promising and lasting solution to 
the spread and pathology of schistosomiasis in endemic 
areas. This study therefore focuses on predicting MHC-
peptide binding epitope and discusses their most relevant 
advantages and drawbacks. 
 
 
METHODOLOGY  
 
Schistosoma mansoni Sm23 protein  
 
S. mansoni Sm23 protein sequence was retrieved from the NCBI 
database with the ID gi|124391|sp|P19331.1|IM23_SCHMA. A blast 
search was performed to screen for the homologues of Sm23 
protein present in other Schistosoma species. The program 
compared the sequences with sequences database and the 
statistical significance of matches. 
 
 
 
 
Protein sequence analysis, subcellular localization and 3D 
modeling 
 
The Sm23 protein structural analysis was done using PSIPRED 
server (Bunchan et al., 2013). The biological and molecular function 
was also predicted, while selecting the ffpred link of PSIPRED 
server (Buchan et al., 2013). The Sm23 secondary structure 
prediction method used in this study was according to Jones (1999) 
(http://bioinf.cs.ucl.ac.uk/psipred). The subcellular localization of the 
protein was predicted using PROTEINPREDICT server 
(https://www.predictprotein.org/) and SignalP (Petersen et al., 
2011). This was done to look at the functional annotation of Sm23 
protein for predicting immunogenicity. The transmembrane topology 
modelling was done according to Nugent and Jones, (2009) which 
also achieved by using the ffpred link of PSIPRED. The initial Sm23 
protein 3D structure modelling was predicted using the 
Phyre2serverb (http://www.sbg.bio.ic.ac.uk/phyre2). 
 
 
Prediction of the T cell epitopes and determination of self-
peptide 
 
The targeted Sm23 protein was analysed for the MHC Class I 
binding epitopes using different algorithms.  BIMAS (Parker et al., 
1994) was used to predict all overlapping peptides with human HLA 
alleles which then produced promiscuous epitopes that bind with 
the HLA showing high affinity. The binding affinity (T1/2) value 
based on half time association of β2 microglobulin from HLA was 
set at a value >=100 for peptide selection. The peptides with low 
affinity were also identified in cases where T(1/2) value was based 
on explicit number alone. Other computational tools like SYFPEITH 
was used to further help in predicting HLA binding T cell epitopes 
on Sm23 protein (http://www.syfpeithi.de/) (Rammensee et al., 
1996). All the high affinity HLA binding peptides were analysed for 
the presence of human-self peptides using HLAPRED. 
 
 
Prediction of sequencelogo plot  
 
In order to determine the peptide characteristics binding motif to a 
MHC complex, the study of a sequence logo plot was carried out. 
The peptide predicted by the above mentioned tools were given as 
input sequences to weblogo tool 
(http://weblogo.threeplusone.com/create.cgi) to create a sequence 
logo of the predicted binder and to look for frequency of each amino 
acid in the 9mer peptide sequences. The sequence logo was 
created by taking all top scoring peptides obtained from SYFPEITH 
database. 
 
 
RESULTS  
 
Homologous and subcellular localization of Sm23 
protein 
 
The blast search revealed that the Sm23 protein is 
specific to S. mansoni, as the protein was not found in 
human beings. Predictprotein 
(https://www.predictprotein.org) server predicted the 
protein as a 23 kDa integral membrane protein, this 
assertion was later support by further protein analysis 
using PSIPRED server to predict the protein  
transmembrane topology (Figure 1B). The 3D structure of  
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Figure 1. A. 3D structure of Sm23 protein; B. Transmembrane topology for Sm23 protein. 
 
 
 
Sm23 protein as predicted by phyre 2 server is shown in 
Figure 1A and the secondary structure analyses of the 
queried protein have revealed that majority of the target 
protein consist mostly of α-helices with few loops and no 
β-sheet (Figure 5). The signalP tool which incorporates a 
prediction of cleavage sites and signal/non-signal peptide 
predicted no presence of signal peptide in the protein. 
Further protein analysis also suggested its biological and 
molecular role in transmembrane transport activity and 
also its function in signal transduction activity (Tables 1 
and 2). 
 
 
Prediction of specific HLA Class I T cell epitope 
 
The predicted epitope with their HLA alleles have been 
summarized in Table 3. Identifying the affinity of 
interaction between the predicted T-cell epitope and HLA 
is essential, as the inclusion of such peptides in vaccine 
design will provide more population coverage and help 
reduce the number of peptides that need to be involved in 
the vaccine (Brusic et al., 2002; Shah et al., 2010). The 
results from predicted overlapping sequences of the 
consensus Sm23 protein to the human 33 Class I HLA 
alleles at various affinities identified 53 nonameric 
peptide sequences which bind both at low and high 
affinity to the different HLA alleles (Table 3). The 
observed binding affinities of the predicted epitopes with 
the HLA alleles shows that alleles like HLA B_2705, HLA 
B_5102 and HLA B_5201 bind to most of the peptides 
showing the tallest bar in the graph (Figure 4) and the 
rear peptides binder like HLA A1, HLA A24, HLA 
Cw_0702, HLA B_2702, B60 and B40 binds to very less 
peptides while some do not bind at all.  
The epitope HLA_A0201 bind to peptide sequences 
85
YMYAFFLVV
93
 and 
83
MLYMYAFFL
91 
at an affinity score 
of 2189 and 3707.145, respectively.
 
Peptides 
8
MRCLKSCVF
16
 AND 
41
SQYGDNLHK
49
 bind to HLA 
B_2705 both at affinity score of 1000. Sequence 
104
VAVVYKDRI
112
 binds to HLA B_5102 at score 1200 
and also bind to HLA B_5101 (score 314.6) and B_5103 
(score 133.1). It is therefore necessary to include 
peptides that bind to the rare HLA alleles in a vaccine 
cocktail to achieve the desired population coverage 
(Parida et al., 2007). The choice of multiple 
computational tools in selecting HLA Class I T-cell 
epitope is to minimize the chances of failure in selection 
of a universal vaccine candidate while ensuring that only 
peptides with positive scores were selected. The 
prediction of presence of human-self peptides using 
HLAPRED showed that the predicted epitopes are 
nonhuman but parasite specific (Figure 3). 
 
 
Anchor motifs and human peptide crosscheck  
 
The sequence logo was predicted while considering the 
predicted peptides and using the anchor position of the
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Table 1. The predicted biological function of Sm23. 
 
GO term Name Prob. SVM reliability 
GO:0055085 Transmembrane transport 0.899 H 
GO:0006810 Transport 0.886 H 
GO:0016192 Vesicle-mediated transport 0.787 H 
GO:0051649 Establishment of localization in cell 0.721 H 
GO:0051641 Cellular localization 0.705 H 
GO:0019222 Regulation of metabolic process 0.681 H 
GO:0008104 Protein localization 0.679 H 
GO:0050877 Neurological system process 0.662 H 
GO:0045184 Establishment of protein localization 0.658 H 
GO:0015031 Protein transport 0.625 H 
GO:0002376 Immune system process 0.603 H 
GO:0007166 Cell surface receptor signaling pathway 0.596 H 
GO:0040011 Locomotion 0.587 H 
GO:0098655 Cation transmembrane transport 0.584 H 
GO:0043269 Regulation of ion transport 0.556 H 
GO:0007268 Synaptic transmission 0.541 H 
GO:0007155 Cell adhesion 0.539 H 
GO:0046907 Intracellular transport 0.538 H 
GO:0034613 Cellular protein localization 0.509 H 
 
 
 
Table 2. Predicted molecular function of Sm23 protein. 
 
GO term Name Prob SVM reliability 
GO:0022857 Transmembrane transporter activity 0.972 H 
GO:0022891 Substrate-specific transmembrane transporter activity 0.964 H 
GO:0005215 Transporter activity 0.957 H 
GO:0003824 Catalytic activity 0.893 H 
GO:0022890 Inorganic cation transmembrane transporter activity 0.845 H 
GO:0015075 Ion transmembrane transporter activity 0.842 H 
GO:0004871 Signal transducer activity 0.792 H 
GO:0046914 Transition metal ion binding 0.746 H 
GO:0008324 Cation transmembrane transporter activity 0.742 H 
GO:0016740 Transferase activity 0.730 H 
GO:0050839 Cell adhesion molecule binding 0.717 H 
GO:0016817 Hydrolase activity, acting on acid anhydrides 0.698 H 
GO:0005198 Structural molecule activity 0.690 H 
GO:0015267 Channel activity 0.640 H 
GO:0016462 Pyrophosphatase activity 0.600 H 
GO:0008270 Zinc ion binding 0.551 H 
GO:0016757 Transferase activity, transferring glycosyl groups 0.531 H 
GO:0004872 Receptor activity 0.529 H 
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Table 2. Cont. 
 
GO:0030246 Carbohydrate binding 0.516 H 
GO:0038023 Signaling receptor activity 0.511 H 
GO:0005509 Calcium ion binding 0.502 H 
GO:0005216 Ion channel activity 0.501 H 
 
*Tables 1 and 2 predictions terms represent terms predicted where SVM training includes assigned gene ontology 
(GO) terms across all evidence code types. SVM reliability is regarded as High (H) when MCC, sensitivity, 
specificity and precision are jointly above a given threshold; otherwise reliability is indicated as low (L). 
 
 
 
Table 3. Peptides of consensus Sm23 protein present in surface exposed loop 
regions and their binding to different HLA alleles. The predicted. 
  
S/N Position Peptide Score HLA alleles Looping 
1 35 VEVKFSQY 45 HLA_A01  
2 83 MLYMYAFFL 3707.145 A_0201 I 
   150 B_2705  
   51.408 A_0205  
3 16 FVLNIICLL 252 A_0205  
   73.172 A_0201  
4 118 ALMTGALDK 60 A3 III 
5 86 MYAFFLVVL 200 A_2402  
   18 B_3902 I 
   400 Cw_0404  
6 174 SVFGAFLKR 28 A_1101 III 
   400 A_6801 I 
   24 A_3101  
7 21 ICCLCSLV 24 B_1402  
8 210 RQIKEYENV 23 B13  
9 207 CLGRQIKEY 21 B_1510 I 
   19.2 Cw_0702  
10 3 TGLTGMRCL 15 B_1510  
11 168 YTEGCVSVF 23 B_1516 I 
   18 B_5701  
   48 B_5801  
12 129 KEITEFMNL 16 B18 I 
   640 B_4001(B60) I 
   21 B_4901  
   26 B_4402  
   90 B_2705  
13 79 ENVCMLYMY 290 A26  
14 8 MRCLKSCVF 24 B_2705  
   18 B_2709 I 
   200 B_2702  
   1000 B_2705  
15 126 KPTKEITEF 20 B_3501  
   60 B_3501  
   80 Cw_0401  
   20 B_5301  
16 116 IDALMTGAL 22 B37 I 
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Table 3. Cont. 
 
    21 B_4701 I 
   40 B60  
17 108 YKDRIDSEI 20 B_3902 I 
18 78 KENVCMLYM 40 B60  
19 97 AELAAAIVA 24 B_4101  
   24 B_4501 I 
   20 B_5001  
   40 B61  
20 56 IAIIVVGVI 314.6 B_5101  
   660 B_5102  
   110 B_5103  
21 12 KSCVFVLNI 27 B_5802  
22 91 LVVLLIAEL 20 B7  
   47.6 A_0205  
23 153 YRGNVPASC 200 B_2705  
24 209 GRQIKEYEN 200 B_2705  
25 41 SQYGDNLHK 1000 B_2705  
26 181 KRNLVIVAC 600 B_2705  
27 112 IDSEIDALM 60 B_3701  
28 192 FGVCFFQLL 120 Cw_0301  
   132 B_5102  
29 100 AAAIVAVVY 40.5 B_4403  
30 104 VAVVYKDRI 314.6 B_5101  
   133.1 B_5103  
   1200 B_5102  
31 204 IACCLGRQI 286 B_5101  
   220 B_5102  
   100 B_5103  
32 51 WQAAPIAII 120 B_5201  
33 15 VFVLNIICL 400 Cw_0401  
34 39 KFSQVGDNL 200 Cw_0401  
35 87 YAFFLVVLL 500 B_5102  
   136 B_5101  
36 177 GAFLKRNLV 550 B_5102  
   200 B_5101  
   132 B_5103  
37 85 YMYAFFLVV 2188.816 A_0201  
   72 A_0205  
   75 B_2705  
38 28 VLIGAGAVV 650.311 A_0201  
39 22 CLLCSLVLI 88.8 A_0201  
40 63 VIILIVSFL 63.167 A_0201  
   23.8 A_0205  
41 186 IVACVAFGV 60.006 A_0201  
42 198 QLLSIVIAC 42.278 A_0201  
43 172 CVSVFGAFC 39.066 A_0201  
   28 A_0205  
44 58 IIVVGVIIL 23.8 A_0205  
45 210 RQIKEYENV 180 B_2705  
46 51 WQAAPIAII 60 B_2705  
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Table 3. Cont. 
 
47 87 YAFFLVVLL 50 B_2705  
48 149 GPDDYRGNV 220 B_5101  
   100 B_5102  
49 99 LAAAIVAVV 143 B_5101  
   100 B_5102  
   100 B_5103  
50 96 IAELAAAIV 143 B_5101  
   55 B_5102  
   121 B_5103  
51 191 AFGVCFFQL 200 Cw_0401  
52 42 KPTKEITEF 80 Cw_0401  
53 88 AFELVVLLI 50 Cw_0401  
 
 
 
 
 
Figure 2. Sequence logo for binding of HLA alleles B_2702, A_0201, B_2705, B_5101, 
B_5102, Cw_0401 showing anchor motifs at position 2 and 9.  
 
 
 
HLA alleles like HLA B_5102, HLA B_5101, HLA B_2705, 
HLA B_2702, HLA B_0201 and HLA Cw_0401 in order to 
find out the frequency of an amino acid at a particular 
position given in the SYFPEITHI database. HLAB_2702 
revealed the amino acids arginine and cysteine at 
position 2 and 9 as anchor motifs, while HLA B_0201 
showed two Leucine, HLA B_2705 with Lysine and 
Leucine, HLA B_5101- Alanine and Isoleucine, HLA 
B_5102- Alanine and Valine and lastly HLA Cw_0401- 
Phenylalanine and Leucine, all at the same position 2 
and 9 as anchor motifs (Figure 2). The sequence 
conservation plot identified maximum peptides binding 
with HLA B_2705 (Figure 4). The predicted peptides were 
identified as potential vaccine candidates when subjected 
to the HLApred server, as it was shown that all predicted 
peptide were completely dissimilar with human host. This 
is important in the prevention of possible autoimmune 
diseases when this vaccine is developed using the 
predicted peptide sequences. 
 
 
DISCUSSION 
 
Investigation using bio-computational approach was
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Figure 3. Signal P-NN result for the signal peptide of Sm23 protein using several artificial 
neural networks and Hidden Markov Models. No signal peptide was detected and it was 
predicted to be an integral membrane protein. Score C, S and Y represent cleavage site score, 
signal peptide score and combination score (derived from C and S scores), respectively. 
 
 
 
 
 
Figure 4. The binding of the predicted peptides from Sm 23 protein to the HLA 
alleles HLA B_2705, B_5102 and B_5201 bind to most of the peptides (tallest chart). 
The alleles like HLA; A1, A24, Cw_0702, B_2702, B60, B40 rarely bind to the 
predicted epitopes. 
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Figure 5. Sm23 protein secondary structure as predicted by Pspired server. 
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conducted on antigen presentation and identification of 
epitopes on different HLA molecules. Interest was on S. 
mansoni, as there is no efficacious vaccine reported 
against this parasite. The highly reported S. mansoni 
Sm23 protein was chosen in this study, in order to predict 
epitope that could be useful as possible vaccine 
candidate in eliciting immunological response against the 
parasite. 
The blast search conducted proved that the 
homologous protein obtained was specific for S. mansoni 
pathogen. It is important to establish the subcellular 
localization of a pathogen protein to predict the most 
accessible pool of potential target using integrative 
approaches (Shah et al., 2010). Hence, the subcellular 
localization information obtained using in silico 
approaches (Psipred, proteinpredict and SignalP) 
confirmed the protein to function in cell surface signal 
pathways and substrate-specific transmembrane 
transporter activity. This information provides valuable 
clues regarding the protein molecular function in drug 
design as secreted or surface exposed protein and 
periplasmic protein were reported to be of primary 
interest due to their potentials as vaccine candidate and 
the ease with which they are accessible to drugs 
(Namrata et al., 2010). In all the 53 peptides epitopes 
predicted from the Sm23 protein with several 
computational tools like ProPred, SYFPEITHI, nHLAPred, 
only 5 promiscuous peptides recorded high 
immunogenicity. The need to use several analytic tools 
for peptide prediction became imperative to select only 
peptides that exhibit positive binding scores under 
extensive analysis by multiple methods because some 
peptide do bind when analysed by one algorithm and do 
not by another. All efforts to predict accurately peptide 
immunogenicity will help reduce several experimental 
efforts (Shah et al., 2010). It should also be noted that the 
prediction of peptide immunogenicity is influenced by 
many factors which include intrinsic physicochemical 
properties and extrinsic factors such as host 
immunological repertoire (Saffari et al., 2008, Namrata 
et al., 2010). 
Namrata et al. (2010) suggested that predicted 
epitopes with high binding affinity are better suited for wet 
lab studies. It was observed that 4 out of the 5 predicted 
epitopes (
85
YMYAFFLVV
93
,
83
MLYMYAFFL
91
, 
8
MRCLKSCVF
16
 and 
104
VAVVYKDRI
112
) with high 
affinities to the HLA alleles are rich with hydrophobic and 
charged amino acids residue thus making them a good 
choice for inclusion in an experimentally drug design 
study. It is has been reported that MHC pockets 
favourably interact with hydrophobic or charged amino 
acid residues at carboxyl to enhance proper binding in 
pockets (Brusic et al., 2002). The interaction between 
peptide and a MHC molecule is mediated through 
anchors on the peptide side chains of amino acids at 
predetermined positions  that  protrude  into  complemen- 
 
 
 
 
tary pockets of the class I groove (Parida et al., 2007; 
Petersen et al., 2004; Namrataet al., 2010). In peptide 
interaction with MHC class I, most of the bonding forces 
are provided by non-allele specific interactions such as 
the bonds between the peptides termini and the class I 
groove (Guo et al., 1993; Namrate et al., 2010). The 
MHC groove pockets determined the specificity of 
peptide interactions with fixed spacing from each other 
and the class I pockets are generally more specific in the 
amino acid residues that they bind (Brusic et al., 1995). 
 
 
Conclusion 
 
The study therefore concluded that with predicted T-cell 
epitopes from Sm23, a transmembrane transporter 
protein using in silico approach can be targeted for 
vaccine constructs while considering its expression 
throughout all schistosome life stages. Also, all high 
binding affinity epitopes will be suited for wet laboratory 
experiment while understanding that vaccine formulations 
against schistosomiasis can be achievable only if the 
epitopes are able to elicit immune response under in vitro 
studies. 
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